Evaluation of patient-controlled intravenous analgesia with remifentanil for labor
10.3760/cma.j.issn.1671-7368.2010.07.019
- VernacularTitle:瑞芬太尼静脉自控式分娩镇痛的临床研究
- Author:
Jian CHEN
;
Xiaoyan YING
- Publication Type:Journal Article
- Keywords:
Anesthetics,intravenous;
Analgesia,obstetrical
- From:
Chinese Journal of General Practitioners
2010;09(7):487-488
- CountryChina
- Language:Chinese
-
Abstract:
The study intended to evaluate the efficacy and safety of patient-controlled intravenous analgesia with remifentanil for labor. Three hundred and two parturients at 37 -42 week of gestation received remifentanil (0. 1μg · kg-1 ·min-1 ) as patient-controlled intravenous analgesia for labor (analgesia group) and their clinical results were compared with those of 221 parturients in labor without intravenous analgesia (control group). Maternal monitoring, including pain scores(VAS), delivery mode, side effects, laboring time was performed for both groups. There was a significant decrease (P ＜0. 01) of pain scores in analgesia group compared with those in control group. Parturients in analgesia group experienced a significantly shorter first stage, than those in the control group ( P ＜ 0. 01). There were no differences between two groups in the rate of cesarean section and instrumental delivery. And there were no significant differences for newborns with Apgar scores less than 7 at the point of one minute. Patient-controlled intravenous analgesia with remifentanil for labor is an effective and safe procedure, which can significantly relieve pain, shorten first stage of labor and has no effect on the delivery mode and Apgar scores of neonates.
